Nonalcoholic fatty liver disease and hepatocellular carcinoma

被引:136
作者
Zoller, Heinz [1 ]
Tilg, Herbert [2 ]
机构
[1] Med Univ Innsbruck, Dept Med 2, Anichstr 35, A-6020 Innsbruck, Austria
[2] Med Univ Innsbruck, Dept Med 1, Anichstr 35, A-6020 Innsbruck, Austria
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2016年 / 65卷 / 08期
关键词
Metabolic liver disease; Hepatoma; Fatty liver; Carcinogenesis; Primary liver tumor; ACYL-COA OXIDASE; NATURAL-HISTORY; CHRONIC HEPATITIS; DIABETES-MELLITUS; RISK-FACTORS; STEATOHEPATITIS; CANCER; PROGRESSION; CIRRHOSIS; OBESITY;
D O I
10.1016/j.metabol.2016.01.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The fastest growing cause of cancer-related death is hepatocellular carcinoma (HCC), which is at least partly attributable to the rising prevalence of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease (NAFLD) encompasses a broad spectrum of conditions, ranging from non progressive bland steatosis to malignant transformation into hepatocellular cancer. The estimated annual HCC incidence in the progressive form of NAFLD non-alcoholic steatohepatitis (NASH) - is about 0.3%. The risk of HCC development is higher in men and increases with age, more advanced fibrosis, progressive obesity, insulin resistance and diabetes mellitus. Studies on the molecular mechanism of HCC development in NAFLD have shown that hepatocarcinogenesis is associated with complex changes at the immunometabolic interface. In line with these clinical risk factors, administration of a choline-deficient high-fat diet to mice over a prolonged period results in spontaneous HCC development in a high percentage of animals. The role of altered insulin signaling in tumorigenesis is further supported by the observation that components of the insulin-signaling cascade are frequently mutated in hepatocellular cancer cells. These changes further enhance insulin-mediated growth and cell division of hepatocytes. Furthermore, studies investigating nuclear factor kappa B (NF-kappa B) signaling and HCC development allowed dissection of the complex links between inflammation and carcinogenesis. To conclude, NAFLD reflects an important risk factor for HCC, develops also in non-cirrhotic livers and is a prototypic cancer involving inflammatory and metabolic pathways. Strengths/weaknesses and summary of the translational potential of the messages in the paper. The systematic review summarizes findings from unbiased clinical and translational studies on hepatocellular cancer in non-alcoholic fatty liver disease. This provides a concise overview on the epidemiology, risk factors and molecular pathogenesis of the NAFL-NASH-HCC sequence. One limitation in the field is that few HCC studies stratify patients by underlying etiology, although the etiology of the underlying liver disease is an important co-determinant of clinical disease course and molecular pathogenesis. Molecular profiling of NAFL and associated HCC holds great translational potential for individualized surveillance, prevention and therapy. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1151 / 1160
页数:10
相关论文
共 50 条
[41]   Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma [J].
Jun Han ;
WenTao Yan ;
Bing Quan ;
MingDa Wang ;
Tian Yang .
Hepatobiliary&PancreaticDiseasesInternational, 2019, 18 (02) :202-202
[42]   From Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: A Systems Understanding [J].
Rozman, Damjana .
DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (02) :238-241
[43]   Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease [J].
Mikuriya, Yoshihiro ;
Tashiro, Hirotaka ;
Kobayashi, Tsuyoshi ;
Kuroda, Shintaro ;
Abe, Tomoyuki ;
Hashimoto, Masakazu ;
Ohdan, Hideki .
LANGENBECKS ARCHIVES OF SURGERY, 2015, 400 (04) :471-476
[44]   Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma [J].
Han, Jun ;
Yan, Wen-Tao ;
Quan, Bing ;
Wang, Ming-Da ;
Yang, Tian .
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (02) :202-202
[45]   Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey [J].
Tokushige, Katsutoshi ;
Hashimoto, Etsuko ;
Horie, Yoshinori ;
Taniai, Makiko ;
Higuchi, Susumu .
JOURNAL OF GASTROENTEROLOGY, 2011, 46 (10) :1230-1237
[46]   Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients [J].
Jain, Deepali ;
Nayak, Nabeen C. ;
Saigal, Sanjiv .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (07) :840-848
[47]   Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows [J].
Costante, Federico ;
Airola, Carlo ;
Santopaolo, Francesco ;
Gasbarrini, Antonio ;
Pompili, Maurizio ;
Ponziani, Francesca Romana .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (09) :1622-1636
[48]   Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver Disease [J].
Frades, Itziar ;
Andreasson, Erik ;
Maria Mato, Jose ;
Alexandersson, Erik ;
Matthiesen, Rune ;
Martinez-Chantar, Ma Luz .
PLOS ONE, 2015, 10 (05)
[49]   Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question [J].
Letitia Adela Maria Streba ;
Cristin Constantin Vere ;
Ion Rogoveanu ;
Costin Teodor Streba .
World Journal of Gastroenterology, 2015, 21 (14) :4103-4110
[50]   Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude [J].
Pocha, Christine ;
Kolly, Philippe ;
Dufour, Jean-Francois .
SEMINARS IN LIVER DISEASE, 2015, 35 (03) :304-317